Sticking Point: Inherent Teachings in Aveed® Case
Last month, the Federal Circuit affirmed the Delaware district court’s decision in Endo Pharms. Sols., Inc. v. Custopharm that patents for Aveed®, a testosterone replacement therapy, were not obvious and, therefore, inherent teachings
[Read More]